News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2
Photo from Chul Kim/X
Apr 26, 2024, 09:26

Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2

Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter:

”First-line treatment for EGFR mutant NSCLC is getting complex with recent approval of FLAURA2.

Would higher risk populations benefit more (e.g. L858R, co-mutations including TP53, RB1, CNS met)?

Thoughtful discussion and great talk by Rachel Sanborn.”

Chul Kim/X

Source: Chul Kim/X

 

cancer Chul Kim EGFR-mutant NSCLC EGFR-mutation FLAURA2 Georgetown University Lung cancer non small cell lung cancer NSCLC OncoDaily Oncology Rachel Sanborn Texas Lung Cancer Conference
Special Coverage
Science
Feb 5, 2025, 05:42
Management of adverse events in patients receiving Tarlatamab for previously treated SCLC by Jacob Sands et al.
Blog
Feb 5, 2025, 00:16
Celebrating Ben Anderson’s Retirement and the Next Phase of Cancer Care Innovation at C/Can
Blog
Feb 5, 2025, 00:14
Joanna Strober: A breakthrough moment for women's healthcare
Blog
Feb 5, 2025, 00:12
Don't miss the opportunity to join the ESO Improving Cancer Outcomes and Leadership course
Blog
Feb 5, 2025, 00:10
Noelene Kotschan: Join Pink Drive in the fight against cancer
Blog
Feb 5, 2025, 00:08
City Cancer Challenge - Where you live and who you are shouldn’t determine the quality of cancer care you receive
Blog
Feb 5, 2025, 00:06
Chris Boshoff: Pfizer’s BRAFTOVI Combination Regimen Significantly Improved PFS and OS in Phase 3 BREAKWATER Trial
Blog
Feb 5, 2025, 00:04
Sandra Demaria: Join Female Leaders in IO at the 7th Annual SITC WIN Leadership Institute
Blog
Feb 5, 2025, 00:03
Tanja Obradovic: How Biotech companies approach oncology drug development and pipeline building/management
Science
Feb 5, 2025, 00:00
Elvina Almuradova: PTC significantly prolongs OS in patients with HER2+ metastatic breast cancer
Blog
Feb 4, 2025, 23:58
Emad Shash: Enhancing sustainable development in Egypt through scientific research and innovation
Blog
Feb 4, 2025, 23:57
Wafaa Rashed: Your Voice Matters in Shaping Maternal-Fetal Genomics Policy